Page last updated: 2024-10-21

4-aminopyridine and Renal Insufficiency

4-aminopyridine has been researched along with Renal Insufficiency in 1 studies

Renal Insufficiency: Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.

Research Excerpts

ExcerptRelevanceReference
"Amifampridine phosphate was given as a single 10 mg (base equivalent) dose, and the plasma and urine PK properties of amifampridine and its 3-N-acetyl metabolite were determined."2.84Acetylator Status Impacts Amifampridine Phosphate (Firdapseā„¢) Pharmacokinetics and Exposure to a Greater Extent Than Renal Function. ( Datt, J; Haroldsen, PE; Ingenito, G; Musson, DG; Sisic, Z, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haroldsen, PE1
Sisic, Z1
Datt, J1
Musson, DG1
Ingenito, G1

Trials

1 trial available for 4-aminopyridine and Renal Insufficiency

ArticleYear
Acetylator Status Impacts Amifampridine Phosphate (Firdapseā„¢) Pharmacokinetics and Exposure to a Greater Extent Than Renal Function.
    Clinical therapeutics, 2017, Volume: 39, Issue:7

    Topics: 4-Aminopyridine; Acetylation; Adult; Aged; Amifampridine; Female; Humans; Kidney; Male; Middle Aged;

2017